Amarin Corp Plc (AMRN)

[heysfguy]

Ralphey may be right on a few things, if he is a dr. and is seeing people's TG data. He can't be sure if there are no CVD benefits to the drug, but he might be convinced based on a relatively small sample that it doesn't do a great job lowering TG levels.

If that's the case, I think others here who take V and are seeing big reductions should speak up right away!

For my case, I have been taking V for a good while now, and my TGs have only gone down a small bit. LDL also went down a small bit. Numbers haven't budged much, and over time I went from 2 MG to 4 MG a day. Does that mean it isn't an effective drug? Can't tell by my numbers alone.

As much as I hope and dream that the R-IT trial shows amazing results in some populations, I am getting seriously stressed out. There's enough doubt gathering about the potential of this drug to make me seriously consider reducing my position before final results are known.

That said, I expect to be holding everything into 2018. In the latest conference call, I feel we were being told that Amarin's news stream should be picking up - including information not directly related to R-IT study. If they don't issue some promising news in terms of their overall business development by mid Q4, my discomfort is bound to grow.